Riversville Capital’s Johnson & Johnson JNJ Stock Holding History

Riversville Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-581	Closed	-$57K	–	17
2014 Q1	$57K	Sell	581 -21,805	-97%	-$2.02M	0.13%	17
2013 Q4	$2.05M	Buy	22,386 +463	+2%	+$42.7K	1.15%	27
2013 Q3	$1.9M	Hold	21,923	–	–	1.05%	29
2013 Q2	$1.88M	Buy	+21,923	New	+$1.86M	1.09%	29

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Riversville Capital's JNJ Position: Q2 2014 in Review

Riversville Capital sold out of Johnson & Johnson (JNJ) in Q2 2014, closing a stake of 581 shares — an estimated $57K sold.

Riversville Capital first reported a position in JNJ in Q2 2013 and held it in 4 quarters. The position peaked at $2.05M in Q4 2013. 1,974 funds tracked by Wall St. Rank hold JNJ as of Q2 2014.

Riversville Capital reported no remaining Johnson & Johnson position as of Q2 2014 after selling out during the quarter.
Riversville Capital sold 581 Johnson & Johnson shares in Q2 2014, an estimated $57K.
Riversville Capital first reported a position in Johnson & Johnson in Q2 2013 and held it in 4 quarters.
Riversville Capital's Johnson & Johnson position peaked at $2.05M in Q4 2013.
1,974 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2014.

Based on Riversville Capital's 13F filing for Q2 2014.